Skip to content
Cybin- 27-04 - Press Release Thumbnails

VIDEO: Cybin (CYBN.NE) to target alcoholism in their CYB003 clinical studies

Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. To read full article: https://equity.guru/2021/04/26/cybin-cybn-ne-to-target-alcoholism-in-their-cyb003-clinical-studies/

Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *